Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
104841
Primer sequences used in PCR.
Published 2023“…Among these biomarkers, C20:5 and C22:6 had significant changes in pairwise comparison among each group. …”
-
104842
NleF inhibits apoptosis induced by TRAIL and staurosporine.
Published 2013“…<p><b>A–C.</b> Percentage of apoptotic HeLa and Caco-2 cells in TRAIL (25 ng/ml) treated (+) and untreated (−) samples. …”
-
104843
<i>Nog</i> repression in senescence.
Published 2011“…<p>(<i>A</i>) Maps around TSS of <i>Nog</i>, showing increase of H3K4me3 and decrease of H3K27me3. …”
-
104844
Summary of subgroup analysis results.
Published 2025“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
-
104845
Data_Sheet_1_Influence of Slow-Paced Breathing on Inhibition After Physical Exertion.xls
Published 2019“…At the physiological level PE significantly increased HR, RF, and decreased CVA [operationalized in this research via the root mean square of successive differences (RMSSD)] in both experiments. …”
-
104846
PRISMA Flow Chart 2020.
Published 2025“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
-
104847
Included and excluded studies.
Published 2025“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
-
104848
DataSheet_1_Serum sulfatide level is associated with severe systemic vasculitis with kidney involvement.docx
Published 2023“…The mean ± standard deviation SS level in the donor, IgAN, IgAV, AAV, and GBM groups was 8.26 ± 1.72, 8.01 ± 2.21, 6.01 ± 1.73, 5.37 ± 1.97, and 2.73 ± 0.99 nmol/mL, respectively. …”
-
104849
Characteristics of included studies.
Published 2025“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
-
104850
Extraction data table.
Published 2025“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
-
104851
The effect of the maladapted type’s growth on the optimal transition probability.
Published 2013“…<p>(A) Two organisms compete () with different transition probabilities, , when types grow at the same rate as types– when the cost of maladapted type () is minimal. …”
-
104852
Table1_Energetic, exergetic, and exergoeconomic analyses of beer wort production processes.pdf
Published 2024“…Additionally, wet steam throttling resulted in a 2.51% increase in exergetic efficiency, a 1.60% drop in exergetic destruction rate, and a decrease in cost rates to 0.0675 USD/s.…”
-
104853
Table3_Gastrointestinal cell injury and perceived symptoms after running the Boston Marathon.pdf
Published 2023“…I-FABP significantly decreased from post-race (3367.5 ± 2633.5 pg/mL) to 24-h post-race (1657.3 ± 950.7 pg/mL, t (39) = −4.228, p < .001, d = −.669). …”
-
104854
Image1_Gastrointestinal cell injury and perceived symptoms after running the Boston Marathon.tiff
Published 2023“…I-FABP significantly decreased from post-race (3367.5 ± 2633.5 pg/mL) to 24-h post-race (1657.3 ± 950.7 pg/mL, t (39) = −4.228, p < .001, d = −.669). …”
-
104855
Table4_Gastrointestinal cell injury and perceived symptoms after running the Boston Marathon.pdf
Published 2023“…I-FABP significantly decreased from post-race (3367.5 ± 2633.5 pg/mL) to 24-h post-race (1657.3 ± 950.7 pg/mL, t (39) = −4.228, p < .001, d = −.669). …”
-
104856
Table3_Gastrointestinal cell injury and perceived symptoms after running the Boston Marathon.pdf
Published 2023“…I-FABP significantly decreased from post-race (3367.5 ± 2633.5 pg/mL) to 24-h post-race (1657.3 ± 950.7 pg/mL, t (39) = −4.228, p < .001, d = −.669). …”
-
104857
Image1_Gastrointestinal cell injury and perceived symptoms after running the Boston Marathon.tiff
Published 2023“…I-FABP significantly decreased from post-race (3367.5 ± 2633.5 pg/mL) to 24-h post-race (1657.3 ± 950.7 pg/mL, t (39) = −4.228, p < .001, d = −.669). …”
-
104858
Table4_Gastrointestinal cell injury and perceived symptoms after running the Boston Marathon.pdf
Published 2023“…I-FABP significantly decreased from post-race (3367.5 ± 2633.5 pg/mL) to 24-h post-race (1657.3 ± 950.7 pg/mL, t (39) = −4.228, p < .001, d = −.669). …”
-
104859
Table1_Gastrointestinal cell injury and perceived symptoms after running the Boston Marathon.pdf
Published 2023“…I-FABP significantly decreased from post-race (3367.5 ± 2633.5 pg/mL) to 24-h post-race (1657.3 ± 950.7 pg/mL, t (39) = −4.228, p < .001, d = −.669). …”
-
104860
Table1_Gastrointestinal cell injury and perceived symptoms after running the Boston Marathon.pdf
Published 2023“…I-FABP significantly decreased from post-race (3367.5 ± 2633.5 pg/mL) to 24-h post-race (1657.3 ± 950.7 pg/mL, t (39) = −4.228, p < .001, d = −.669). …”